131 related articles for article (PubMed ID: 23230738)
21. Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.
Luo SD; Chen YJ; Liu CT; Rau KM; Chen YC; Tsai HT; Chen CH; Chiu TJ
Biomed Res Int; 2015; 2015():508587. PubMed ID: 26491674
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
23. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
[TBL] [Abstract][Full Text] [Related]
25. [Expression of extracellular matrix metalloproteinase inducer in laryngeal squamous cell carcinoma].
Ma J; Qiao Z; Wu S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jun; 19(12):545-7. PubMed ID: 16176007
[TBL] [Abstract][Full Text] [Related]
26. MMP-11 promoted the oral cancer migration and Fak/Src activation.
Hsin CH; Chou YE; Yang SF; Su SC; Chuang YT; Lin SH; Lin CW
Oncotarget; 2017 May; 8(20):32783-32793. PubMed ID: 28427180
[TBL] [Abstract][Full Text] [Related]
27. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
[TBL] [Abstract][Full Text] [Related]
28. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H
Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697
[TBL] [Abstract][Full Text] [Related]
29. [The correlation between neck lymphy node metastasis and matrixmetalloproteinase-2 expression at the invasive tumor front of oral squamous cell carcinomas].
Liu LK; Li YN; Jiang HB; He ZX; Yi XZ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):106-8. PubMed ID: 15190788
[TBL] [Abstract][Full Text] [Related]
30. COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
Li TJ; Cui J
Asian Pac J Trop Med; 2013 Aug; 6(8):640-3. PubMed ID: 23790336
[TBL] [Abstract][Full Text] [Related]
31. [Expression of connective tissue growth factor (CTGF), osteopontin (OPN) and clinical significances in the laryngeal squamous cell carcinoma tissues].
Li Y; Lu Y; Ceng Y; Yang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Feb; 21(3):121-3. PubMed ID: 17441427
[TBL] [Abstract][Full Text] [Related]
32. [The expression and significance of osteopontin and its receptor CD44v6 in oral squamous carcinoma].
Jiang L; Zhao LY; He J; Zhao YF; Wu Y; Liu Y; Jiang XZ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Jun; 26(3):248-51. PubMed ID: 18705503
[TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical significance of CD147 and MMP-2
in squamous cell carcinoma and adenocarcinoma of the lungs].
Wang S; Li B; Wang S; Li Y; Li J
Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):710-4. PubMed ID: 21924036
[TBL] [Abstract][Full Text] [Related]
34. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
35. [Expression of matrix metalloproteinases in metastatic lesions of cutaneous squamous cell carcinoma].
Chen X; Kanekura T; Zhang GY
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):297-300. PubMed ID: 12536717
[TBL] [Abstract][Full Text] [Related]
36. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
37. May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?
Shrestha B; Bajracharya D; Byatnal AA; Kamath A; Radhakrishnan R
Pathol Oncol Res; 2017 Jan; 23(1):197-206. PubMed ID: 27853937
[TBL] [Abstract][Full Text] [Related]
38. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
[TBL] [Abstract][Full Text] [Related]
39. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M
Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476
[TBL] [Abstract][Full Text] [Related]
40. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
